- GlaxoSmithKline is one of the eight largest pharmaceutical companies in the world.
- The company's revenue continues to grow QoQ with a 9.3% increase in Q3 2021 compared to Q2 2021. Vaccine sales were £2,174 million in Q3 2021, up 38.4% from Q2.
- Sales of Sotrovimab for COVID-19 were £114 million in Q3 2021, up 612.5% from Q2 2021.
- ViiV Healthcare, majority-owned by GlaxoSmithKline, wins litigation against Gilead Sciences over HIV drug.
- The dividend yield is 4.57%, which is one of the largest in the pharmaceutical industry.
For further details see:
GlaxoSmithKline: 4.57% Dividend Yield And Cure For COVID-19 And HIV